Trial Profile
Evaluation of the effect of symptomatic upper respiratory infections on pharmacological characteristics of Technosphere/insulin in subjects with diabetes mellitus after a meal challenge
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2015
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Antihypoglycaemics
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors MannKind Corporation
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 22 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Apr 2008 New trial record.